domain
mer
plpro
effect
abil
process
viral
polyprotein
act
interferon
antagonist
involv
deubiquitin
deisgyl
cellular
protein
test
hypothesi
domain
requir
catalyt
function
mer
plpro
vitro
xray
structur
mer
determin
compar
plpro
contain
ntermin
domain
structur
nearli
ident
enzym
reveal
intact
structur
substratebind
loop
moreov
catalysi
differ
substrat
purport
inhibitor
reveal
differ
catalyt
effici
substrat
specif
inhibit
chang
thermal
stabil
observ
enzym
conclud
catalyt
core
mer
plpro
ie
without
domain
suffici
catalysi
stabil
vitro
util
evalu
potenti
inhibitor
platform
structurebas
drug
design
coronavirus
cov
envelop
posit
sens
singlestrand
rna
virus
caus
mild
sever
upper
respiratori
tract
infect
human
approxim
year
emerg
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
emerg
identifi
far
countri
casefat
rate
although
cov
wellrecogn
global
pathogen
antivir
intervent
avail
thu
better
understand
molecular
mechan
facilit
viral
pathogenesi
replic
may
permit
design
target
therapeut
cov
merscov
classifi
sublineag
c
genu
betacoronaviru
conserv
genom
size
kb
among
cov
first
kilobas
locat
end
rna
genom
encod
two
open
read
frame
translat
host
ribosom
gener
two
respect
viral
polyprotein
process
two
virusencod
cystein
proteas
term
papainlik
proteas
plpro
proteas
togeth
two
proteas
cleav
polyprotein
produc
nonstructur
protein
nsp
essenti
format
replicas
complex
henc
rna
replic
studi
focus
multifunct
put
drug
target
plpro
locat
nonstructur
protein
fig
scientif
report
doi
addit
function
cleav
viral
polyprotein
requisit
nsp
sarscov
plpro
also
viral
ubiquitinspecif
proteas
vusp
structur
fold
almost
ident
human
usp
famili
sar
plpro
highli
effici
deubiquitin
dub
enzym
abil
rapidli
hydrolyz
isopeptid
bond
protein
posttransl
modifi
cellular
ubiquitinlik
ubl
molecul
ubiquitin
ub
interferonstimul
gene
two
key
regul
innat
immun
respons
other
also
shown
sarscov
plpro
cov
plpro
display
substanti
differ
substrat
specif
certain
polyub
chain
importantli
dubdeisgyl
activ
shown
play
import
role
antagon
host
innat
immun
respons
promot
viral
replic
although
precis
role
activ
antagon
yet
determin
interestingli
cov
rna
genom
encod
two
ubl
domain
within
denot
accord
locat
multidomain
protein
domain
sarscov
previous
name
ubl
first
identifi
lab
xray
structur
studi
found
resid
directli
adjac
nterminu
plpro
catalyt
domain
sinc
origin
structur
domain
found
conserv
among
cov
date
includ
merscov
murin
hepat
viru
mhv
infecti
bronchiti
viru
ibv
howev
function
role
viral
pathogenesi
rna
replic
remain
enigmat
far
major
studi
aim
understand
role
viral
ubl
cov
replic
focus
domain
due
locat
rna
genom
potenti
modul
enzymat
activ
plpro
exampl
investig
function
sarscov
mhv
found
fold
crucial
maintain
plpro
structur
integr
vitro
interestingli
cellbas
assay
sarscov
plpro
without
domain
longer
abl
antagon
pathway
involv
host
innat
immun
respons
therebi
act
ifn
antagonist
howev
mechan
lead
loss
function
well
understood
enzym
retain
proteas
dub
activ
case
mhv
singl
point
mutat
domain
found
reduc
thermal
stabil
papainlik
proteas
domain
render
enzym
dub
defici
cell
mutat
insert
back
viru
mutant
viru
attenu
infect
mice
abil
replic
induc
protect
immun
respons
wildtyp
viru
studi
reveal
domain
could
use
strategi
attenu
cov
pathogenesi
lead
us
investig
function
domain
merscov
unexpectedli
recent
cellbas
studi
use
differ
truncat
form
merscov
mer
suggest
domain
might
pivot
plpro
enzym
activ
origin
thought
cellbas
assay
merscov
appear
retain
multipl
enzymat
function
unlik
sarscov
preserv
abil
act
ifn
antagonist
intrigu
discoveri
engend
hypothesi
studi
merscov
domain
requir
plpro
catalyt
function
stabil
vitro
report
seri
xray
structur
kinet
studi
merscov
construct
elucid
import
domain
merscov
stabil
substrat
specif
enzymat
catalysi
well
evalu
efficaci
report
merscov
plpro
inhibitor
mer
plpro
color
pink
color
gray
respect
cleavag
site
color
accordingli
indic
arrow
light
blue
green
domain
indic
b
summari
current
plp
xray
structur
smallest
catalyt
unit
determin
studi
pdb
code
xray
structur
determin
first
mhv
sarscov
ibv
merscov
plpro
contain
domain
indic
c
sdspage
analysi
purifi
merscov
kda
kda
use
activ
assay
crystal
protein
estim
puriti
densitometri
domain
sinc
function
merscov
plpro
observ
independ
domain
cellular
assay
sought
determin
structur
segreg
catalyt
core
design
merscov
plasmid
express
catalyt
core
plpro
fig
amino
acid
encod
domain
nterminu
singl
cystein
cterminu
plpro
remov
cystein
remov
aid
crystal
express
purifi
use
nearli
ident
condit
procedur
merscov
plpro
flank
ntermin
domain
merscov
catalyt
domain
remain
stabl
throughout
purif
minim
precipit
activ
loss
result
molecular
weight
merscov
remov
octahistidin
tag
kda
kda
respect
fig
crystal
space
group
p
one
biolog
activ
monom
asymmetr
unit
xray
data
collect
final
xray
data
collect
refin
statist
summar
tabl
final
xray
structur
model
merscov
rvalu
r
work
r
free
merscov
structur
contain
catalyt
domain
plpro
three
subdomain
thumb
finger
palm
fig
secondari
structur
arrang
catalyt
domain
ident
structur
describ
ref
seven
helic
six
thumb
domain
one
finger
domain
fourteen
total
strand
four
thumb
domain
four
two
partial
strand
finger
domain
four
two
partial
strand
palm
domain
one
helix
finger
domain
hkl
ob
f
ob
f
calc
observ
calcul
structur
factor
respect
e
r
free
calcul
use
data
set
chosen
random
exclud
refin
similar
mer
structur
catalyt
merscov
structur
also
modifi
mercaptoethanol
bme
partial
occup
fig
weak
electron
densiti
catalyt
observ
final
f
f
c
omit
map
fig
due
partial
modifi
observ
occupi
least
one
altern
posit
order
accommod
bulki
modifi
residu
hand
contrast
previous
report
unbound
merscov
plpro
structur
includ
protein
data
bank
pdb
code
unpublish
strong
f
f
c
map
welldefin
electron
densiti
observ
flexibl
loop
encompass
residu
merscov
structur
fig
substratebind
loop
observ
ubbound
merscov
plpro
structur
result
abl
readili
build
refin
entir
loop
respons
substrat
bind
inhibitor
recognit
cov
plpro
altogeth
xray
structur
data
suggest
catalyt
domain
merscov
plpro
highli
stabl
absenc
domain
structur
comparison
plpro
without
domain
current
four
structur
mer
plpro
flank
ntermin
domain
determin
absenc
bound
ligand
determin
domain
elicit
effect
conform
merscov
plpro
catalyt
core
superimpos
structur
fig
b
merscov
plpro
catalyt
domain
observ
adopt
conform
nearli
ident
structur
domain
intact
result
rootmeansquaredevi
rmsd
c
residu
align
c
residu
catalyt
triad
align
well
enzym
except
occupi
conform
near
modifi
cystein
group
truncat
domain
appear
caus
slight
deviat
ridg
helix
thumb
domain
due
loss
two
helix
residu
also
observ
variat
posit
zinc
atom
finger
domain
reminisc
open
close
conform
observ
ubbound
complex
observ
suggest
zincfing
bind
motif
high
flexibl
may
provid
explan
weaker
electron
densiti
increas
bfactor
associ
region
includ
residu
turnsubstratebind
loop
merscov
observ
studi
also
indic
turn
b
magnifi
view
elongatedleft
helic
wheel
projectionright
ridg
helix
show
similar
two
structur
c
electron
densiti
map
associ
catalyt
triad
residu
mercaptoethanol
shown
green
mesh
f
f
c
blue
mesh
f
c
f
f
c
electron
densiti
omit
map
catalyt
triad
residu
omit
calcul
contour
final
f
c
map
contour
observ
resid
two
posit
occup
refin
one
slightli
higher
occup
electron
densiti
map
associ
substratebind
loop
residu
contain
turn
shown
green
mesh
f
f
c
blue
mesh
f
c
contour
respect
entir
loop
could
model
observ
densiti
repres
stick
atom
panel
cd
color
follow
nitrogen
dark
blue
oxygen
red
sulfur
yellow
carbon
light
blue
scientif
report
doi
determin
enzymat
activ
plpro
depend
domain
determin
steadyst
kinet
paramet
catalyz
hydrolysi
three
differ
ubbas
substrat
ubamc
zrlrggamc
commonli
use
assess
plpro
dub
deisgyl
proteolyt
activ
kinet
assay
substrat
perform
sidebysid
enzym
assay
plate
ident
assay
condit
kinet
respons
enzym
increas
concentr
substrat
shown
supplementari
fig
unabl
reach
satur
zrlrggamc
peptid
substrat
concentr
concentr
begin
approach
concentr
rang
wherebi
inner
filter
effect
amc
fluorophor
confound
assay
therefor
firstord
rang
kinet
data
fit
line
obtain
slope
appar
k
cat
k
catalyt
effici
contrast
enzym
could
satur
ubamc
substrat
kinet
data
fit
michaelismenten
equat
obtain
individu
k
cat
k
valu
result
kinet
paramet
enzym
three
substrat
summar
tabl
suggest
previou
work
cell
kinet
paramet
catalyz
hydrolysi
ubamc
zrlrggamc
substrat
nearli
ident
two
enzym
compar
k
cat
k
valu
zrlrggamc
peptid
enzym
hydrolyz
ubamc
time
time
effici
merscov
plpro
without
domain
hydrolyz
substrat
effici
ubamc
although
turnov
number
k
cat
ident
higher
catalyt
effici
mainli
due
lower
k
valu
observ
assum
k
k
plpro
may
bind
tighter
compar
ub
result
kinet
studi
support
hypothesi
domain
requir
merscov
plpro
dub
deisgyl
proteolyt
activ
vitro
recent
studi
demonstr
merscov
plpro
intact
domain
broad
ub
chain
specif
base
cleavag
variou
diubiquitin
ub
chain
isopeptid
linkag
merscov
plpro
propos
use
singl
monoubiquitin
recognit
subsit
ub
bind
process
ub
chain
possibl
merscov
domain
could
function
assist
plpro
abil
discrimin
differ
ub
linkag
therefor
test
abil
merscov
plpro
without
intact
domain
process
differ
ub
isopeptid
linkag
includ
linear
ub
link
via
aminotermin
met
residu
incub
substrat
merscov
hour
analyz
cleav
product
sdspage
result
shown
fig
indic
domain
impact
abil
plpro
recogn
differ
isopeptid
linkag
merscov
plpro
capabl
recogn
process
ub
linkag
except
peptid
linkag
linear
linkag
effici
cleav
nearli
monoubiquitin
time
cours
howev
linkag
partial
react
unreact
ub
speci
result
also
consist
recent
find
merscov
plpro
without
domain
still
abl
modifi
ub
warhead
support
hypothesi
domain
involv
substrat
recognit
sinc
polyubiquitin
chain
preferenti
util
host
innat
immun
respons
pathway
evalu
kinet
hydrolysi
tetraubiquitin
ub
chain
evalu
domain
involv
higherord
polyubiquitin
chain
process
cleavag
assay
perform
hour
time
cours
reaction
product
analyz
variou
time
point
minut
hour
use
sdspage
fig
b
ub
substrat
without
addit
enzym
serv
neg
control
cleavag
assay
fig
fig
nearli
ident
reaction
catalyz
merscov
plpro
without
domain
substrat
readili
convert
monoubiquitin
speci
hour
appar
accumul
ub
form
consist
previou
report
togeth
result
suggest
domain
merscov
plpro
involv
signific
recognit
cleavag
polyubiquitin
chain
substrat
kinet
paramet
rlrggamc
ubamc
tabl
kinet
paramet
use
three
differ
fret
ubbas
substrat
steadyst
valu
report
mean
standard
deviat
determin
minimum
triplic
measur
bestfit
slope
shown
supplementari
fig
b
valu
k
app
nonsatur
substrat
approxim
k
cat
k
scientif
report
doi
plpro
nearli
ident
substrat
recognit
pattern
kinet
paramet
room
temperatur
possibl
domain
may
alter
thermost
catalyt
domain
higher
temperatur
test
possibl
perform
circular
dichroism
cd
melt
studi
enzym
monitor
cd
signal
function
temperatur
determin
thermal
melt
temperatur
averag
valu
three
independ
experi
found
tabl
next
perform
experi
differ
human
usp
absenc
presenc
reduc
agent
mm
dtt
immedi
appar
data
present
supplementari
fig
compound
capabl
signific
inhibit
viral
human
usp
enzym
absenc
reduc
agent
presenc
reduc
agent
inhibit
enzym
either
elimin
significantli
reduc
result
summar
tabl
stand
strong
contrast
obtain
lee
et
al
report
compound
compound
studi
strongli
inhibit
merscov
ic
sarscov
ic
plpro
presenc
reduc
agent
mm
dtt
mm
gsh
anoth
strike
observ
data
present
tabl
compound
nonselect
ie
promiscu
potent
inhibit
multipl
usp
homolog
evalu
use
recent
describ
cellbas
assay
name
pglo
biosensor
assay
cov
plpro
activ
cell
transfect
plasmid
dna
express
inact
form
luciferas
either
wildtyp
catalyt
mutant
plpro
found
express
sarscov
merscov
plpro
activ
biosensor
select
sarscov
plpro
inhibitor
develop
compound
block
sarscov
plpro
activ
contrast
addit
effect
either
merscov
fig
sarscov
fig
plpro
activ
biosensor
assay
support
confirm
vitro
result
compound
lose
potenc
physiolog
reduc
environ
investig
function
domain
merscov
plpro
substrat
recognit
catalysi
structur
stabil
inhibit
purport
small
molecul
inhibitor
also
report
first
xray
crystal
structur
cov
plpro
without
flank
domain
found
use
xray
crystallographi
remov
domain
merscov
plpro
alter
structur
catalyt
domain
significantli
chang
structur
stabil
determin
melt
temperatur
deriv
cd
melt
curv
steadyst
kinet
studi
reveal
domain
associ
merscov
plpro
requir
enzymat
function
includ
dub
deisgyl
proteolyt
activ
addit
examin
merscov
plpromedi
catalysi
toward
differ
polyubiquitin
substrat
differ
isopeptid
linkag
reveal
domain
influenc
highord
ub
chain
process
ub
chain
specif
overal
studi
indic
core
catalyt
domain
mer
plpro
robust
enzym
use
cellbas
vitro
assay
make
highli
amen
highthroughput
screen
evalu
potenti
inhibitor
whether
domain
within
merscov
particip
discrimin
differ
ub
chain
linkag
still
remain
unclear
find
suggest
howev
domain
like
involv
function
merscov
plpro
capabl
cleav
varieti
differ
chain
linkag
though
chain
favor
substrat
recognit
merscov
plpro
therefor
similar
mhv
find
support
recognit
cleavag
ub
chain
merscov
plpro
independ
presenc
domain
merscov
plpro
also
hydrolyz
polyubiquitin
chain
monoubiquitin
equal
rate
either
without
domain
rapid
process
chain
monoubiquitin
suggest
merscov
plpro
similar
mhv
util
monoubiquitin
recognit
singl
subsit
cleav
ub
chain
contrast
sarscov
plpro
prefer
util
ub
recognit
hydrolyz
substrat
exampl
sarscov
plpro
hydrolyz
chain
effici
use
two
ub
bind
site
across
subsit
oppos
chain
recogn
singl
subsit
structur
basi
ub
recognit
recent
reveal
via
crystal
structur
sarscov
plpro
complex
ub
support
previou
model
bind
pocket
ridg
helix
sarscov
plpro
immedi
adjac
domain
activ
engag
distal
ub
ub
substrat
propos
ridg
helix
merscov
plpro
may
activ
particip
substrat
bind
sarscov
plpro
howev
conclud
two
residu
remov
ridg
helix
specif
residu
involv
polyubiquitin
catalysi
mutagenesi
done
region
altogeth
find
coupl
aforement
studi
clearli
show
merscov
sarscov
plpro
util
differ
mechan
recogn
cleav
host
protein
specif
merscov
plpro
like
contain
subsit
origin
xray
structur
sarscov
plpro
reveal
first
time
presenc
ubl
domain
cov
establish
first
known
vusp
defin
new
class
semin
work
vusp
set
stage
new
discoveri
includ
bioinformat
studi
homolog
human
usp
reveal
ubl
fold
resembl
grasp
architectur
ub
predict
present
least
human
usp
locat
ubl
domain
found
either
nand
ctermini
embed
within
catalyt
core
plethora
ubl
domain
resid
within
human
usp
suggest
may
play
signific
function
role
tightli
orchestr
process
protein
degrad
well
critic
signal
process
thu
far
function
ubl
domain
usp
attribut
alter
enzym
catalysi
specif
recruit
bind
partner
mediat
process
includ
cellular
local
traffick
signal
transduct
although
extens
studi
character
ubl
domain
human
usp
function
viral
ubl
domain
biolog
system
remain
elus
initi
function
domain
evalu
cellcultur
sarscov
plpro
domain
found
essenti
plpro
abil
act
ifn
antagonist
inhibit
phosphoryl
b
signal
interestingli
domain
remov
plpro
sarscov
maintain
dub
proteas
activ
howev
character
sarscov
vitro
pursu
due
instabl
express
purif
interestingli
recent
studi
sarscov
merscov
construct
express
purifi
vitro
enzym
maintain
catalysi
toward
ub
warhead
compar
plpro
domain
result
suggest
domain
may
involv
mechan
substrat
recognit
catalysi
plpro
howev
domain
found
import
mhv
thermal
stabil
previou
work
evalu
effect
conserv
singl
mutat
domain
found
decreas
enzymat
activ
physiolog
temperatur
attenu
mutant
viru
mice
propos
similar
mutat
could
provok
unravel
effect
introduc
domain
adjac
plpro
howev
case
merscov
plpro
show
complet
remov
domain
merscov
plpro
result
plpro
catalyt
core
still
abl
maintain
stabil
catalysi
vitro
cell
also
investig
whether
compound
recent
report
potent
select
inhibitor
merscov
sarscov
plpro
could
also
inhibit
merscov
plpro
without
domain
purin
analogu
first
synthes
potenti
anticanc
agent
late
earli
compound
use
reactant
design
arrhythmia
antivir
drug
well
compound
set
regul
plant
growth
year
seldom
report
literatur
identifi
inhibitor
sarscov
lee
et
al
studi
refer
compound
identifi
inhibitor
sarscov
via
highthroughput
screen
found
inhibit
sarscov
mixedtyp
inhibit
ic
lee
et
al
also
perform
similar
ht
studi
time
merscov
sarscov
plpro
identifi
compound
refer
studi
compound
report
compound
inhibit
plpro
cov
low
micromolar
ic
valu
base
mechan
inhibit
enzym
predict
act
competit
inhibitor
merscov
plpro
alloster
inhibitor
sarscov
plpro
bind
mechan
describ
take
place
either
activ
site
pocket
unknown
alloster
site
contrast
aforement
studi
lee
et
al
demonstr
aka
compound
nonselect
nonreduc
condit
inhibit
viral
human
cystein
proteas
test
confirm
panassay
interfer
compound
pain
also
evalu
inhibitori
abil
reduc
condit
either
place
dtt
biochem
assay
use
natur
reduc
environ
cell
found
reduc
agent
either
greatli
diminish
elimin
abil
inhibit
merscov
sarscov
plpro
usp
test
possibl
explan
compound
may
show
efficaci
nonreduc
condit
could
compound
bind
nonspecif
manner
viral
human
usp
promot
reversibleoxid
activ
site
cystein
anoth
explan
could
chemic
reduc
agent
may
directli
compet
inhibitor
bind
activ
site
reduc
agent
dtt
bme
modifi
activ
site
cystein
bulki
modifi
cystein
form
bme
reduc
agent
observ
crystal
structur
support
fact
inhibitor
may
abl
bind
reduc
condit
due
encumb
activ
site
pocket
howev
unabl
inhibit
merscov
sarscov
plpro
natur
reduc
condit
cell
indic
inhibit
compound
complex
like
nonspecif
clear
data
data
present
literatur
poor
select
among
cystein
proteas
lack
inhibitori
potenc
cellbas
assay
greatli
reduc
inhibitori
potenc
vitro
assay
presenc
reduc
agent
therefor
like
pain
pursu
lead
compound
therapeut
develop
use
summari
catalyt
core
merscov
stabl
highli
activ
without
domain
mer
exhibit
substrat
specif
profil
merscov
intact
domain
suggest
domain
necessari
normal
merscov
plpro
function
mer
highli
amen
enzym
inhibitori
studi
easili
form
crystal
diffract
high
resolut
overal
properti
mer
suggest
may
ideal
construct
structurebas
inhibitor
design
effort
express
purif
merscov
gene
encod
incorpor
ctermin
end
residu
sitedirect
mutagenesi
result
fig
plasmid
dna
subject
dna
sequenc
use
purdu
genom
core
facil
confirm
correct
construct
gener
two
liter
super
broth
media
inocul
ml
e
coli
cell
transform
either
centrifug
g
minut
harvest
cell
g
frozen
day
purif
frozen
cell
pellet
thaw
resuspend
ml
buffer
mm
tri
ph
mm
nacl
mm
imidazol
mm
bme
glycerol
supplement
mgml
lysozym
gml
dnase
resuspend
cell
lyse
ice
sonic
use
branson
digit
sonifi
amplitud
minut
puls
delay
lyse
cell
debri
remov
centrifug
g
minut
clarifi
lysat
load
onto
ml
histrap
ff
column
ge
healthcar
precharg
ni
equilibr
buffer
b
mm
tri
ph
mm
nacl
mm
imidazol
mm
bme
glycerol
wash
unbound
protein
column
volum
ml
buffer
b
plpro
elut
ml
linear
gradient
buffer
b
flow
rate
mlmin
tag
remov
addit
tobacco
etch
viru
tev
proteas
mg
tev
mg
plpro
incub
hour
overnight
enzym
pass
hitrap
column
unbound
untag
plpro
collect
flowthrough
untag
plpro
concentr
mgml
use
amicon
ultrafiltr
centrifug
devic
kda
mw
cutoff
buffer
exchang
buffer
mm
tri
ph
mm
nacl
mm
dtt
glycerol
final
purifi
protein
fig
flashfrozen
liquid
nitrogen
l
aliquot
store
week
crystal
harvest
use
pin
nylon
loop
transfer
briefli
cryoprotect
solut
contain
reservoir
solut
supplement
glycerol
immedi
flashcool
plung
liquid
nitrogen
crystal
place
spine
puck
transport
advanc
photon
sourc
synchrotron
ap
argonn
nation
laboratori
anl
xray
data
collect
crystal
use
beamlin
life
sciencescollabor
access
team
lscat
xray
data
collect
singl
merscov
crystal
use
rotat
xray
data
index
process
scale
use
determin
initi
phase
structur
molecular
replac
phaser
perform
use
structur
merscov
apo
pdb
code
search
model
model
build
refin
result
structur
solut
contain
one
molecul
asymmetr
unit
complet
use
coot
phenix
refin
use
stimul
anneal
initi
refin
limit
bia
final
data
collect
statist
refin
paramet
shown
tabl
initi
rate
reaction
convert
initi
veloc
v
mmin
use
extinct
coeffici
product
maximum
amount
amc
releas
reaction
reaction
rate
v
e
min
measur
triplic
plot
function
substrat
concentr
satur
substrat
kinet
paramet
k
cat
k
determin
use
sigmaplot
enzym
kinet
modul
nonlinear
regress
michaelismenten
equat
cat
k
cat
defin
number
substrat
molecul
hydrolyz
plpro
per
minut
per
activ
site
k
repres
substrat
concentr
reaction
rate
halfmaxim
kinet
paramet
catalyt
effici
k
cat
k
enzym
determin
standard
deviat
k
cat
k
calcul
use
follow
equat
k
cat
k
associ
error
k
cat
k
valu
respect
nonsatur
peptid
substrat
appar
k
cat
k
valu
approxim
use
linear
regress
modul
graphpad
follow
equat
reaction
without
enzym
serv
neg
control
hour
reaction
mixtur
quench
ld
sampl
buffer
life
technolog
load
onto
gradient
sdspage
ub
concentr
g
g
per
well
linear
respect
ub
cleavag
assay
chain
lifesensor
inc
perform
use
enzym
concentr
buffer
composit
neg
control
describ
reaction
quench
five
differ
time
point
minut
hour
analyz
sdspage
load
g
per
well
cd
melt
studi
protein
sampl
load
mm
quartz
cell
starna
cell
magnet
stir
bar
ml
potassium
phosphat
ph
cd
signal
measur
nm
temperatur
increas
step
interv
rate
protein
denatur
use
chirascan
circular
dichroism
cd
spectromet
appli
photophys
equip
temperatur
control
bath
quantum
northwest
inc
averag
enzym
calcul
three
independ
experi
determin
maxima
first
deriv
peak
use
sigmaplot
enzymat
activ
human
usp
monitor
ubamc
buffer
inhibitor
incub
enzym
minut
reaction
initi
substrat
monitor
fluoresc
use
biotek
synergi
multimod
micropl
reader
ic
determin
data
nonreduc
condit
fit
hill
equat
biosensor
assay
cell
transfect
ng
ng
prltk
promega
ng
plasmid
dna
express
indic
viral
proteas
empti
vector
hour
posttransfect
cell
lyse
passiv
lysi
buffer
promega
l
lysat
assay
luciferas
activ
use
white
bottom
plate
corn
dual
luciferas
activ
reagent
promega
evalu
express
protein
western
blot
detect
proteas
perform
briefli
l
lysat
mix
l
sampl
buffer
protein
separ
electrophoresi
sdspage
transfer
pvdf
membran
probe
mous
invitrogen
previous
describ
hrpconjug
goatantimous
southern
biotech
use
secondari
antibodi
detect
use
western
light
chemiluminesc
reagent
plu
perkin
elmer
visual
use
fluorochem
imag
